Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 128, Issue 1, Pages 109-117
Publisher
Springer Nature
Online
2010-08-03
DOI
10.1007/s10549-010-1072-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro
- (2011) Irina N. Alimova et al. CELL CYCLE
- Metformin induces unique biological and molecular responses in triple negative breast cancer cells
- (2011) Bolin Liu et al. CELL CYCLE
- Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
- (2010) Adem Kalender et al. Cell Metabolism
- Metformin: A Therapeutic Opportunity in Breast Cancer
- (2010) A. M. Gonzalez-Angulo et al. CLINICAL CANCER RESEARCH
- Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
- (2010) M. Bodmer et al. DIABETES CARE
- Estradiol stimulates Akt, AMP-activated protein kinase (AMPK) and TBC1D1/4, but not glucose uptake in rat soleus
- (2009) Nicole H. Rogers et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Is it Time to Test Metformin in Breast Cancer Clinical Trials?
- (2009) M. Cazzaniga et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Subcellular Localization of Cyclic AMP-Responsive Element Binding Protein-Regulated Transcription Coactivator 2 Provides a Link between Obesity and Breast Cancer in Postmenopausal Women
- (2009) Kristy A. Brown et al. CANCER RESEARCH
- Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission
- (2009) H. A. Hirsch et al. CANCER RESEARCH
- Design, conduct, and analyses of Breast International Group (BIG) 1-98: A randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
- (2009) Anita Giobbie-Hurder et al. Clinical Trials
- New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes
- (2009) G. Libby et al. DIABETES CARE
- Metformin Inhibits Aromatase via an Extracellular Signal-Regulated Kinase-Mediated Pathway
- (2009) Suman Rice et al. ENDOCRINOLOGY
- Targeting of tamoxifen to enhance antitumour action for the treatment and prevention of breast cancer: The ‘personalised’ approach?
- (2009) Hiltrud Brauch et al. EUROPEAN JOURNAL OF CANCER
- Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia
- (2009) Evrim Erdemoglu et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Metformin, insulin, breast cancer and more…
- (2009) Lev M Berstein Future Oncology
- Metformin is a potent inhibitor of endometrial cancer cell proliferation—implications for a novel treatment strategy
- (2009) Leigh A. Cantrell et al. GYNECOLOGIC ONCOLOGY
- Metformin in Breast Cancer: Time for Action
- (2009) Pamela J. Goodwin et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
- (2009) Sao Jiralerspong et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
- (2009) Mitch Dowsett et al. JOURNAL OF CLINICAL ONCOLOGY
- LKB1 Catalytic Activity Contributes to Estrogen Receptor α Signaling
- (2009) Suchita Nath-Sain et al. MOLECULAR BIOLOGY OF THE CELL
- Targeting of cancer energy metabolism
- (2009) Sara Rodríguez-Enríquez et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor?
- (2008) Vuk Stambolic et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Sirwan M. Hadad et al. BREAST CANCER RESEARCH AND TREATMENT
- Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model
- (2008) Kathryn N. Phoenix et al. BREAST CANCER RESEARCH AND TREATMENT
- Effect of Fenretinide and Low-Dose Tamoxifen on Insulin Sensitivity in Premenopausal Women at High Risk for Breast Cancer
- (2008) H. Johansson et al. CANCER RESEARCH
- Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer
- (2008) Pamela J. Goodwin et al. Clinical Breast Cancer
- Decreased BRCA1 confers tamoxifen resistance in breast cancer cells by altering estrogen receptor–coregulator interactions
- (2008) J Wen et al. ONCOGENE
- The effect of tamoxifen on the genital tract
- (2008) Sandra A. Polin CANCER IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now